
Bal Pharma Limited has informed the Exchange regarding a press release dated February 08, 2023, titled "BAL Pharma Limited showcased strong revenue growth for Q3 & 9MFY23 results against adverse market conditions".
Filed with NSE ·

Bal Pharma Limited has informed the Exchange regarding a press release dated February 08, 2023, titled "BAL Pharma Limited showcased strong revenue growth for Q3 & 9MFY23 results against adverse market conditions".
6ix hasn’t read this filing yet.
Follow Bal Pharma into a list and get an email when it puts out news.
Follow Bal Pharma